SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-045429
Filing Date
2019-08-13
Accepted
2019-08-13 08:05:47
Documents
2
Period of Report
2019-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-17059_18k.htm 8-K 31618
2 EX-99.1 a19-17059_1ex99d1.htm EX-99.1 67669
  Complete submission text file 0001104659-19-045429.txt   100417
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38586 | Film No.: 191018275
SIC: 2836 Biological Products, (No Diagnostic Substances)